Vanadium, a versatile biochemical effector in chemical rat mammary carcinogenesis

Nutrition and Cancer

Volumn 51, Issue 2, 2005, Pages 184-196

  Ray, Rajarshi Sankar ^a   Basu, Mitali ^a   Ghosh, Balaram ^a   Samanta, Kartick ^a   Chatterjee, Malay ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; AMMONIUM VANADATE; BIOLOGICAL MARKER; CARCINOGEN; COPPER; IRON; SINGLE STRANDED DNA; TRACE ELEMENT; VANADIUM; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER MODEL; CANCER PREVENTION; CELL STRUCTURE; CHROMOSOME ABERRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA STRAND BREAKAGE; FEMALE; GASTROINTESTINAL CARCINOMA; GENOMIC INSTABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOMA; NONHUMAN; RAT; TUMOR XENOGRAFT; X RAY;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CELL SURVIVAL; CHROMOSOME ABERRATIONS; COPPER; DISEASE MODELS, ANIMAL; DNA DAMAGE; FEMALE; IRON; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, X-RAY EMISSION; VANADIUM; ZINC;

ANIMALIA;

EID: 19544364464     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5102_9     Document Type: Article

References (50)

1. Fenech M and Ferguson LR: Vitamins/minerals and genomic stability in humans. Mutat Res 475, 1-6, 2001.
2. Elberg G, Li J, and Shechter Y: Mechanism of action of vanadium in mediating the biological effects of insulin. In Vanadium in the Environment, Part 2, Nriagu JO (ed). New York: Wiley-Interscience, 1998, pp 277-296.
3. Sakurai H and Tsuji A: Antidiabetic action of vanadium complexes in animals: blood glucose normalizing effect, organ distribution of vanadium, and mechanism of insulin-mimetic action. In Vanadium in the Environment, Part 2, Nriagu JO (ed). New York: Wiley-Interscience, 1998, pp 297-316.
4. Cruz TF, Morgan A, and Min W: In vitro and in vivo antineoplastic effects of orthovanadate. Mol Cell Biochem 153, 161-166, 1995.
5. Bishayee A and Chatterjee M: Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital. Br J Cancer 71, 1214-1220, 1995.
6. Thompson HJ, Chasteen ND, and Meeker LD: Vanadyl (IV) sulphate inhibits chemically induced mammary carcinogenesis. Carcinogenesis 5, 849-851, 1984.
7. Bishayee A, Oinam S, Basu M, and Chatterjee M: Vanadium chemoprevention of 7,12-dimethylbenz(α)anthracene-induced rat mammary carcinogenesis: probable involvement of representative hepatic phase I and phase II xenometabolising enzymes. Breast Cancer Res Treat 63, 133-145, 2000.
8. Stenafou D, Collery P, and Evangelou A: Beneficial effects of a vanadium complex with cysteine, administered at low dose on benzo(alpha)pyrene induced Leiomyosarcoma in Wister rats. Anticancer Res 18, 3609-3613, 1998.
9. Narla RK, Dong Y, D'Cruz OJ, Navara C, and Uckun FM: Bis(4,7-dimethyl-1, 10-phenanthroline) sulfatooxovanadium (IV) as a novel apoptosis-inducing anticancer agent. Clin Cancer Res 6, 1546-1556, 2001.
10. Kopf-Maier P: Cytostatic non-platinum metal complexes: new perspective for the treatment of cancer? Naturwissenschaften 74, 374-382, 1987.
11. Crans DC, Bunch RJ, and Theisen LA: Interaction of trace levels of vanadium (IV) and vanadium (V) in biological system. J Am Chem Soc 111, 7597-7607, 1989.
12. Bishayee A, Banik S, Marimuthu P, and Chatterjee M: Vanadium-mediated suppression of diethlynitrosamine-induced chromosomal aberrations in rat hepatocytes and its correlation with induction of hepatic glutathione and glutathione S-transferase. Int J Oncol 102, 413-423, 1997.
13. Cohen MD, Klein CB, and Costa M: Forward mutations and DNA protein crosslinking induced by ammonium metavanadate in cultured mammalian cells. Mutat Res 269, 141-148, 1992.
14. Fenech M: Chromosomal damage rate, aging and diet. Ann NY Acad Sci 854, 23-36, 1998.
15. Ames BN: Micronutrients prevent cancer and delay aging. Toxicol Lett 102-103, 5-18, 1998.
16. Ames BN: DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 475, 7-20, 2001.
17. Bonassi S, Hagmar L, Stromberg U, Motagud AH, Tinnerberg H, et al.: Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European study group on cytogenetic biomarkers and health. Cancer Res 60, 1619-1625, 2000.
18. Costa I, Solanas M, and Escrich E: Histopathologic characterization of mammary neoplastic lesions induced with 7,12-dimethylbenz (α)anthracene in the rat: a comparative analysis with human breast tumors. Arch Pathol Lab Med 126, 915-927, 2002.
19. Lawrence TS, Canman CE, Maybaum J, and Davis MA: Dependence of etoposide-induced cytotoxity and topoisomerase II mediated DNA strand breakage on the intracellular ionic environment. Cancer Res 49, 4775-4779, 1989.
20. Stohs SJ and Bagchi D: Oxidative mechanism in the toxicity of metal ions. Free Radic Biol Med 18, 321-336, 1995.
21. 3 on carcinogen modified liver enzymes and tumor incidence in experimental rat mammary carcinogenesis. Eur J Cancer Prev 18, 159-168, 1999.
22. Bishayee A, Roy S, and Chatterjee M: Characterization of selective induction and alteration of xenobiotic biotransforming enzymes by vanadium during diethylnitrosamine induced chemical rat liver carcinogenesis. Oncol Res 11, 41-53, 1999.
23. Bishayee A and Chatterjee M: Inhibition of altered liver cell foci and persistent nodule growth by vanadium during diethylnitrosamine induced hepatocarcinogenesis in rat. Anticancer Res 15, 455-462, 1995.
24. Young S and Hallowes RC: Pathology of tumours in laboratory animals. In Pathology of Tumours in Laboratory Animals, Turusov VS (ed). Lyon, France: International Agency for Research on Cancer, 1972, vol 1, pp 31-74.
25. Greiner JW, DiPaolo JA, and Evans CH: Carcinogen-induced pheno htypic alterations in mammary epithelial cells accompanying the development of neoplastic transformation. Cancer Res 43, 273-278, 1983.
26. Scudiero DA, Shoemaker RH, Paul KD, Monks A, Tierney S, et al.: Evaluation of a soluble tetrazolium/formazoin assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48, 4827-4833, 1988.
27. Sarkar A, Basak R, Bishayee A, Basak J, and Chatterjee M: β-carotene inhibits rat liver chromosomal aberrations and DNA chain break after a single injection of diethylnitrosamine. Br J Cancer 76, 855-861, 1997.
28. Gupta RC: Non-random binding of the carcinogen N-hydroxy-2- acetlyaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci USA 81, 6943-6947, 1984.
29. 32P-labelling test for DNA damage. Proc Natl Acad Sci USA 78, 6126-6129, 1981.
30. 32P-post labelling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents. Carcinogenesis 5, 231-243, 1984.
31. Basak J: Estimation of single-strand breaks induced in the dried film of DNA by high-energy alpha particle from a cyclotron. Ind J Biochem Biophys 33, 35-38, 1996.
32. Yarmoneko SP: Radiation Biology in Humans and Animals. Moscow: Mir, 1988.
33. Land H, Parada LF, and Weinberg RA: Cellular oncogenes and multistep carcinogenesis. Science 222, 771-778, 1983.
34. Arnold A, Cossman J, Bakshi A, Jaffe ES, Waldmann TA, et al.: Immunoglobin gene rearrangements as unique clone markers in human lymphoid neoplasms. N Engl J Med 309, 1593-1599, 1983.
35. Sager R: Genetic instability, suppression and human cancer. In Gene Regulation in the Expression of Malignancy, Sachs L (ed). London: Oxford University Press, 1985.
36. Kawanishi S, Hiraku Y, Murata M, and Oikawa S: The role of metals in site-specific DNA damage with reference to carcinogenesis. Free Radic Biol Med 32, 822-832, 2002.
37. Cousins RJ: A role for zinc in the relation of gene expression. Proc Nutr Soc 57, 307-311, 1998.
38. Dreasti IE: Free radical pathology and the genome. In Trace Elements, Micronutrients and Free Radicals, Dreasti IE (ed). Totowa. NJ: Humana Press, 1991, pp 149-169.
39. Faluuk K: The molecular basis for the role of zinc in developmental biology. Mol Cell Biochem 188, 41-48, 1998.
40. - in vitro and in vivo. Free Radic Biol Med 16, 29-33, 1994.
41. Fridovich I: Oxygen toxicity: a radical explanation. J Exp Biol 201, 1203-1209, 1998.
42. Beckman KB and Ames BN: The free radical theory of ageing matures. Physiol Rev 78, 547-581, 1998.
43. Larramendy M, Mello-Filho AC, Martins EA, and Meneghini R: Iron mediated induction of sister chromatid exchange by hydrogen peroxide and superoxide anion. Mutat Res 178, 57-63, 1987.
44. Martins EAL, Robalinho RL, and Meneghini R: Oxidative stress induces activation of a cytosolic protein responsible for control of iron uptake. Arch Biochem Biophys 316, 128-134, 1995.
45. Pantopounlos K and Hentxe MW: Rapid responses to oxidative stress mediated by iron regulatory proteins. EMBO J 14, 2917-2924, 1995.
46. De Freilas JM, Liba A, Meneghini R, Valentino JS, and Gralla EB: Yeast lacking Cu-Zn superoxide dismutase show altered iron haemostasis: role of oxidative stress in iron metabolism. J Biol Chem 275, 11645-11649, 2000.
47. Linder MC: Biochemistry of Copper. New York: Plenum Press, 1991.
48. Barrow L and Tamer MS: Copper distribution among serum proteins in pediatric liver disorders and malignancies. Eur J Clin Invest 18, 555-560, 1988.
49. Maria C and Linder: Copper and genomic stability in mammals. Mutat Res 475, 141-152, 2001.
50. Bender MA, Preston RJ, Leonard RC, Pyatt BE, and Gooch PC: Chromosomal aberration and sister-chromatid exchange frequencies in peripheral blood lymphocytes of a large human population sample. II. Extension of age range. Mutat Res 212, 149-154, 1982.